Exclusive

Publication

Byline

Dr Reddy's net profit beats estimates despite 14% dip, set for India semaglutide launch

New Delhi, Jan. 21 -- Hyderabad-based Dr Reddy's Laboratories beat street estimates in the third quarter, reporting revenue of Rs.8,726.8 crore and profit after tax (PAT) of Rs.1,210 crore, with stead... Read More


Pharma Q3 preview: Core business, India growth to offset Revlimid pain

New Delhi, Jan. 15 -- As India's pharmaceutical sector kicks off its earnings season for the quarter ended December on Friday, analysts expect muted margins. A key reason for this is the loss of paten... Read More


Pharma Q3 preview: India growth, base business may offset US headwinds

New Delhi, Jan. 15 -- As India's pharmaceutical sector kicks off its earnings season for the quarter ended December on Friday, analysts expect muted margins. A key reason for this is the loss of paten... Read More


Pee Safe raises $32 million from OrbiMed to accelerate expansion

New Delhi, Jan. 14 -- Pee Safe, a personal hygiene brand, plans to expand its offline and online presence after raising $32 million ( Rs.290 crore) from global healthcare-focused private equity firm O... Read More